img, .hide-comment-buttons #singleCommentHeader .formContainer >.title, .hide-comment-buttons #loginButtonContainer display: none; /* Expandable MPU fix */ #side .x300 overflow: visible!important; /* Collapsing Skyscraper fix */ .ad div.skyscraper height:auto!important;padding:0px!important; .ad div#mpu.skyscraper height:600px!important; Glaxo in swoop for eczema diet (click through the next site) drug - Business News - Business - The Independent Saturday 20 December 2014

Apps

eBooks

i Jobs

Dating

Shop
News UK Home News
UK Politics
Scottish independence
Crime
Weird News

World Europe
Americas
Middle East
Asia
Africa
Australasia
World Politics
World History
Novaya Gazeta (English)
WW1 Moments

Business Business News
Business Comment
Business Analysis & Features
Sharewatch
SME
Market News
Market Epic
Market Heatmaps
Market Screener
Business Directory
ES Business Connections
Create a business profile

People
Science
Environment Climate Change
Green Living
Nature

Media Opinion
TV & Radio
Press
Online
Advertising

Technology
Education News
Schools
Further
Higher
Primary Tables 2011
Secondary Tables 2012
Training & Courses
MBA & Executive

Images
Obituaries
Diary
Corrections
Newsletter
Appeals

Video
People
Voices
Sport
Tech
Life
Property
Arts + Ents
Travel
Money
IndyBest
Student
Offers
Cuba and America Immigration Homeless Veterans Campaign - Donate George Osborne Greece Michael Gove News >Business >Business News Glaxo in swoop for eczema drug Tom Bawden Tom Bawden Tom Bawden is Energy and Resources Correspondent for The Independent and Evening Standard.
More articles from this journalist Follow Tom Bawden Wednesday 13 June 2012
Print Your friend's email address Your email address Note: We do not store your email address(es) but your IP address will be logged to prevent abuse of this feature. Please read our Legal Terms & Policies A A A Email The drugs giant GlaxoSmithKline has agreed to buy Toctino, a key new eczema treatment, for up to almost